Red cell antibodies in frequently transfused patients with myelodysplastic syndrome

Annals of Hematology

Volumn 80, Issue 6, 2001, Pages 330-333

  Stiegler, G ^a   Sperr, W ^b   Lorber, C ^a   Fabrizii, V ^b   Hocker P ^a   Panzer, S ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Leukocyte depletion; Myelodysplastic syndrome; Red blood cell unit; Red cell antibody

Indexed keywords

ALLOANTIBODY; ERYTHROCYTE ANTIBODY; ERYTHROCYTE ANTIGEN;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; BLOOD FILTRATION; CONTROLLED STUDY; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNE RESPONSE; KIDNEY FAILURE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HEMATOLOGIC DISEASES; HUMANS; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES;

EID: 0034961127     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770100308     Document Type: Article

References (19)

1. Myelodysplastic disorders
2. Use of leukocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization
3. Prevention of refractoriness and HLA alloimmunization using filtered blood products
4. Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration
5. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components
6. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leukocytes
7. An animal model for allogeneic donor platelet refractoriness: The effect of the time of leukodepletion
8. Increased tumor necrosis factor α (TNFα), interleukin-1, and interleukin-6 (II-6) levels in the plasma of stored platelet concentrates: Relationship between TNFα and II-6 levels and febrile transfusion reactions
9. Evidence for a multistep pathogenesis of a myelodysplastic syndrome
10. Immunological abnormalities in myelodysplastic syndromes
11. Myelodysplasia, vasculitis and anti-neutrophil cytoplasma antibodies
12. Autoimmune-thrombocytopenia and SLE in a patient with 5q-anomaly and deletion of the c-fms oncogene
13. Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy
14. Unusual occurrence of six anti-erythrocyte alloantibodies in an Rh(D)-negative man with myelodysplastic syndrome
15. The French-American-British Cooperative Group: Proposals for the classification of the myelodyplastic syndromes
16. Quantitative evaluation of elution methods for red cell antibodies
17. Immune abnormalities in renal failure and hemodialysis
18. The costimulatory function of antigen-presenting cells
19. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary HLA-alloimmunization and refractoriness: A randomized prospective study